Dapagliflozin Prevents NOX- and SGLT2-Dependent Oxidative Stress in Lens Cells Exposed to Fructose-Induced Diabetes Mellitus.
Ying-Ying ChenTsung-Tien WuChiu-Yi HoTung-Chen YehGwo-Ching SunYa-Hsin KungTzyy-Yue WongChing-Jiunn TsengPei-Wen ChengPublished in: International journal of molecular sciences (2019)
In rats with fructose-induced DM, dapagliflozin downregulates RAGE-induced NADPH oxidase expression in LECs via the inactivation of GLUTs and a reduction in ROS generation. These novel findings suggest that the SGLT2 inhibitor dapagliflozin may be a candidate for the pharmacological prevention of cataracts in patients with DM.